....With tweaks, brains in a dish may yield clear clues to autism.. Com ajustes, os cérebros em um prato podem produzir pistas claras para o autismo.. Con ajustes, los cerebros en un plato pueden dar pistas claras sobre el autismo....

March 22, 2017
....Neurological Studies and References..Estudos Neurológicos e Referências..Estudios y Referencias Neurológicas....
....Original Language: ..Idioma original:..Idioma original:....
....Share It Now:..Compartilhe:..Compartir:....

The best way to understand something complex is, perhaps, to rebuild it. As a child, that’s exactly what I used to do with so many toys, from robots to trains. The rebuilt toy did not always work, but the exercise taught me how functional units, when pieced together, could work as a sophisticated machine.

As a neuroscientist, I continue to apply this lesson from my childhood to understand the human brain.

The human brain is perhaps the most complex system in the universe. It can orchestrate sophisticated behaviors and thoughts, such as language, tool use, self-awareness, symbolic thought, consciousness and cultural learning. From intricate networks in the brain emerge extraordinary technological and artistic masterpieces.

But sophistication comes at a high price. Subtle alterations in the intricate dance of early development can lead to conditions such as autism and schizophrenia.

To find clues to these alterations, my research team and I have adapted my old approach to toys: We are working to fine-tune an intricate model of the brain in a dish, built from stem cells that can mature into brain cells.

Using these so-called ‘cerebral organoids,’ or ‘mini-brains,’ we have shown that neurons derived from individuals with autism are different from those derived from neurotypical people1. We’ve also tested how environmental factors such as the Zika virus can cause microcephaly and other birth defects2. Other research groups are using mini-brains to investigate molecular and cellular mechanisms of disease, to find potential biomarkers and to test drugs.

Scientists consider mini-brains in a dish useful as semi-realistic in vitro models of human brains. As much as I believe in their potential, however, we have yet to reproduce certain critical features of the human brain in these organoids. Until we do, we cannot fully explore the possibilities of this approach.


Past efforts to rebuild the human brain from scratch involved stem cells from early embryos. These stem cells are responsible for generating all tissues in the body. In the lab, we can expand these so-called pluripotent stem cells and give them ‘instructions,’ in the form of recipes with specific nutrients and growth factors, to become brain cells.

Scientists can also generate stem cells from living people, starting with mature blood, skin or dental pulp cells, which are easy to obtain3. The reprogrammed cells, called induced pluripotent stem cells, capture all of the donor’s genomic information.

When allowed to float freely in a solution, these cells will self-assemble into brain-like spheres that resemble the brains of human fetuses between 8 and 10 weeks gestation. Depending on the recipe, these cells can form different brain regions. My lab has focused on the prefrontal cortex, a region implicated in the asocial aspects of autism.

Yet this organoid model of the human brain has some critical limitations.

First, it is unlikely that we are growing these cells in the ideal culture conditions, because we don’t really know what is in the milieu of factors in which the human brain grows. Most of the protocols are based on rodent brain literature, and thus, several factors are likely to be missing or overrepresented.

To induce proper maturation, leading to more organized brain structures, we will likely need to optimize our culture protocols. By doing this, it is possible that we could use cerebral organoids to model even late-onset disorders, such as Alzheimer’s or Parkinson’s disease.

Short circuits:

Second, the brain is not only composed of neurons. Immune cells in the brain called microglia are also important in several neurological conditions. They have a different embryonic origin than neurons and are not generally in the brain organoids. Still, it is possible to generate these cells in parallel and add them to the organoids later on.

Similarly, blood vessels are also not present in these organoids, leading to an abnormal distribution of nutrients to the cells. Scientists are working on bio-printed artificial blood vessels or mixing cells that give rise to blood vessels with brain organoids, hoping they will self-organize into an intricate vascular system. Researchers also are transplanting a human organoid in an animal, so that the animal’s blood vessels naturally vascularize it4.

Lastly, and perhaps most conceptually important, we have not yet characterized these organoids at the functional level. It is unclear if the neurons in the organoid are making the right connections.

Most of the work to date is limited to mimicking gene expression patterns or anatomical organization. It is unclear if these organoids will allow us to model subtle alterations in neuronal networks and circuits that accompany conditions such as autism.

Aside from the technical bottlenecks, there is at least one obvious ethical question that comes up from the idea of thousands of human mini-brains growing inside labs. “Can the brains think?” is a question I often get from journalists.

Based on the idea that these mini-brains are not receiving or processing information, many scientists believe that thoughts arising from these brains would be unlikely. However, it is plausible that these mini-brains could process information, creating something similar to a human mind. This would open a new set of ethical concerns that would dictate how far the science can go.

Assuming such concerns can be put to rest, mini-brains could yield a multitude of discoveries and may even bring about a form of personalized medicine. In the near future, doctors may test various drugs and doses on a person’s mini-brain before writing out a prescription.

  1. Marchetto M. C. et al. Mol. Psychiatry Epub ahead of print (2016) PubMed
  2. Cugola F.R. et al. Nature 534, 267-271 (2016) PubMed
  3. Takahashi K. et al. Cell131, 861-872 (2007) PubMed
  4. Boutin M.E. et al. J. Neurosci. Methods Epub ahead of print (2017) PubMed

This information is presented for educational purposes only. 1Pure. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by 1Pure and none should be inferred.

....This information is presented for educational purposes only. 1Pure provides this information to give an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by 1Pure and none should be inferred. ..Esta informação é apresentada apenas para fins educacionais. 1Pure fornece informações para dar uma compreensão das aplicações potenciais do canabidiol. Links para sites de terceiros não constituem um endosso dessas organizações por parte da 1Pure e nada deve ser inferido. ..1Pure proporciona información para dar una comprensión de las aplicaciones potenciales del canabidiol. Los enlaces a sitios de terceros no constituyen un endoso de estas organizaciones por parte de 1Pure y no se debe inferir nada. ....

Alysson Muotri
Dr. Muotri earned a BSc in Biological Sciences from the State University of Campinas in 1995 and a Ph.D. in Genetics in 2001 from University of Sao Paulo, in Brazil. He moved to the Salk Institute as Pew Latin America Fellow in 2002 for a postdoctoral training in the fields of neuroscience and stem cell biology. He has been a Professor at the School of Medicine, University of California in San Diego since 2008. His research focuses on modeling neurological diseases, such as Autism Spectrum Disorders, using human induced pluripotent stem cells. His lab has developed several techniques to culture human neurons and glia for basic research and drug-screening platforms. He has received several awards, including the prestigious NIH Director’s New Innovator Award, NARSAD, Emerald Foundation Young Investigator Award, Surugadai Award from Tokyo University, Rock Star of Innovation from CONNECT, NIH EUREKA Award among others.

....Related Posts..Postagens Relacionadas..Materias Relacionadas....

....DISCLAIMER: Any and all statements made in regard to Cannabinoid products are not expressed as medical claims. Our intention is to educate, not to suggest results nor to encourage action on the part of the reader. 1Pure is not responsible for, and expressly disclaims all liability for, damages of any kind arise out of use, reference to, or reliance on any information contained within the site. The information contained within the site is periodically updated, there is no guarantee to the accuracy of the information. Nothing on this site is intended to operate as legal advice, please seek your own legal advice. FDA DISLAIMER: The statements and products referred to throughout this site have not been evaluated by the FDA. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult a physician or your health care provider. Always consult a medical doctor before modifying your diet, using any new product, drug, supplement, or doing new exercises. We recommend you educate yourselves on the scientific / nutritional facts. .. AVISO DE ISENÇÃO DE RESPONSABILIDADE: Todas e quaisquer declarações feitas em relação aos produtos contendo canabinóides não são expressas como reivindicações médicas. Nossa intenção é educar, não sugerir resultados nem encorajar que o leitor tome qualquer iniciativa. A 1Pure não se responsabiliza e expressamente se abstém de toda a responsabilidade por danos de qualquer tipo que sugirem ou que façam referência a qualquer informação contida no site. As informações contidas no site são atualizadas periodicamente, mas não há garantia de sua precisão. Nada neste site é destinado a funcionar como aconselhamento jurídico. Por favor, procure o seu próprio aconselhamento jurídico. AVISO DE ISENÇÃO DE RESPONSABILIDADE DO AGÊNCIA DE VIGILÂNCIA SANITÁRIA: As declarações e produtos especificados neste site não foram avaliados pela Agência de Vigilância Sanitária (Anvisa) nem pelo Ministério da Agricultura. Eles não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. Se você tem alguma condição de saúde ou sente desconforto, consulte um médico ou outro profissional de saúde. Sempre consulte um médico antes de modificar sua dieta e fazer uso de qualquer produto, droga ou suplemento novo, ou caso mude seus exercícios. Recomendamos que pesquisem mais sobre as informações científicas e nutricionais do produto. ..CLÁUSULA DE EXENCIÓN DE RESPONSABILIDAD: Cualquiera y todas las declaraciones hechas con respecto a los productos de cannabinoides no se expresan como reclamaciones médicas. Nuestra intención es educar, no sugerir resultados o estimular al lector a tomar cualquier iniciativa.  La 1Pure no se hace responsable y expresamente se abstiene de toda responsabilidad por cualquier tipo de daño que emerger o se referir a cualquier información contenida en este sitio. La información contenida en este sitio se actualiza periódicamente, pero no hay ninguna garantía de su exactitud. Nada en este sitio tiene la intención de actuar como un consejo legal. Por favor, busque su propio consejo legal. CLÁUSULA DE EXENCIÓN DE RESPONSABILIDAD DE LA AGENCIA REGULATORIA DE MEXICO Las declaraciones y los productos mencionados en este sitio no han sido evaluados por la Agencia Regulatoria de Mexico. Ellos no se destinan a diagnosticar, tratar, curar o prevenir ninguna enfermedad. Si usted tiene alguna condición de salud o siente molestias, consulte a un médico u otro profesional de la salud. Siempre consulte a un médico antes de cambiar su dieta y hacer uso de cualquier producto, medicamento o suplemento nuevo, o si cambia sus entrenamientos. Recomendamos que haga más investigaciones sobre la información científica y nutricional del producto. ....